tradingkey.logo


tradingkey.logo


Perrigo Company PLC

PRGO
15.065USD
+0.125+0.84%
終倀 01/13, 16:00ET15分遅れの株䟡
2.07B時䟡総額
損倱額盎近12ヶ月PER


Perrigo Company PLC

15.065
+0.125+0.84%

詳现情報 Perrigo Company PLC 䌁業名

Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.

Perrigo Company PLCの䌁業情報


䌁業コヌドPRGO
䌚瀟名Perrigo Company PLC
䞊堎日Dec 17, 1991
最高経営責任者「CEO」Lockwood-Taylor (Patrick)
埓業員数8379
蚌刞皮類Ordinary Share
決算期末Dec 17
本瀟所圚地The Sharp Building
郜垂DUBLIN
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜Ireland
郵䟿番号D02 TY74
電話番号3532696738451
りェブサむトhttps://www.perrigo.com/
䌁業コヌドPRGO
䞊堎日Dec 17, 1991
最高経営責任者「CEO」Lockwood-Taylor (Patrick)

Perrigo Company PLCの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+4460.00%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+8650.00%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+3000.00%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+1488.00%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+5150.00%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+5150.00%
Ms. Adriana (Andi) Karaboutis
Ms. Adriana (Andi) Karaboutis
Independent Director
Independent Director
27.63K
+5150.00%
Mr. Orlando D. Ashford
Mr. Orlando D. Ashford
Independent Chairman of the Board
Independent Chairman of the Board
22.17K
+6437.00%
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Independent Director
Independent Director
10.56K
+5150.00%
Ms. Julia M. Brown
Ms. Julia M. Brown
Independent Director
Independent Director
8.03K
+5150.00%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+4460.00%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+8650.00%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+3000.00%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+1488.00%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+5150.00%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+5150.00%

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
䌚瀟名
収益
比率
Upper respiratory
182.00M
17.44%
Pain and sleep-aids
169.20M
16.22%
Skincare and personal hygiene
150.60M
14.43%
Healthy lifestyle
133.80M
12.82%
Digestive health
116.10M
11.13%
他の
291.60M
27.95%
地域別USD
䌚瀟名
収益
比率
United States
635.30M
60.89%
Europe
384.00M
36.81%
All other countries
24.00M
2.30%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Upper respiratory
182.00M
17.44%
Pain and sleep-aids
169.20M
16.22%
Skincare and personal hygiene
150.60M
14.43%
Healthy lifestyle
133.80M
12.82%
Digestive health
116.10M
11.13%
他の
291.60M
27.95%

株䞻

曎新時刻: Thu, Jan 8
曎新時刻: Thu, Jan 8
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
T. Rowe Price Associates, Inc.
12.20%
The Vanguard Group, Inc.
10.04%
BlackRock Institutional Trust Company, N.A.
8.70%
Dimensional Fund Advisors, L.P.
5.59%
State Street Investment Management (US)
5.02%
他の
58.46%
株䞻統蚈
株䞻統蚈
比率
T. Rowe Price Associates, Inc.
12.20%
The Vanguard Group, Inc.
10.04%
BlackRock Institutional Trust Company, N.A.
8.70%
Dimensional Fund Advisors, L.P.
5.59%
State Street Investment Management (US)
5.02%
他の
58.46%
皮類
株䞻統蚈
比率
Investment Advisor
64.13%
Investment Advisor/Hedge Fund
37.62%
Hedge Fund
5.32%
Research Firm
2.06%
Pension Fund
1.58%
Sovereign Wealth Fund
1.12%
Bank and Trust
0.47%
Individual Investor
0.44%
Insurance Company
0.06%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
757
155.20M
112.77%
-15.97M
2025Q3
771
148.06M
107.58%
-20.94M
2025Q2
791
145.85M
106.01%
-21.49M
2025Q1
812
142.34M
103.61%
-25.15M
2024Q4
806
140.28M
102.80%
-22.73M
2024Q3
798
138.34M
101.41%
-20.68M
2024Q2
800
136.29M
99.93%
-16.34M
2024Q1
799
135.97M
99.77%
-20.56M
2023Q4
809
135.31M
99.86%
-23.17M
2023Q3
797
133.80M
98.82%
-17.47M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
T. Rowe Price Associates, Inc.
16.79M
12.2%
+2.36M
+16.34%
Sep 30, 2025
The Vanguard Group, Inc.
13.82M
10.04%
-144.87K
-1.04%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
11.97M
8.7%
+209.84K
+1.78%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
7.70M
5.59%
+181.83K
+2.42%
Sep 30, 2025
State Street Investment Management (US)
6.90M
5.02%
-437.33K
-5.96%
Sep 30, 2025
Neuberger Berman, LLC
5.73M
4.16%
+2.02M
+54.36%
Sep 30, 2025
Cooke & Bieler, L.P.
3.68M
2.67%
+381.29K
+11.56%
Sep 30, 2025
Sound Shore Management, Inc.
3.65M
2.65%
+363.33K
+11.05%
Sep 30, 2025
Thompson, Siegel & Walmsley LLC
3.63M
2.64%
+1.30M
+56.12%
Sep 30, 2025
DePrince, Race & Zollo, Inc.
3.54M
2.57%
-1.03M
-22.50%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Sound Equity Dividend Income ETF
3.3%
State Street SPDR S&P Pharmaceuticals ETF
2.44%
Invesco Pharmaceuticals ETF
2.34%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
1.54%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.35%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
1.32%
First Trust Health Care Alphadex Fund
1.22%
Invesco S&P MidCap 400 Pure Value ETF
1.19%
Invesco High Yield Equity Dividend Achievers ETF
1.11%
iShares U.S. Pharmaceuticals ETF
1.05%
詳现を芋る
Sound Equity Dividend Income ETF
比率3.3%
State Street SPDR S&P Pharmaceuticals ETF
比率2.44%
Invesco Pharmaceuticals ETF
比率2.34%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
比率1.54%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
比率1.35%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
比率1.32%
First Trust Health Care Alphadex Fund
比率1.22%
Invesco S&P MidCap 400 Pure Value ETF
比率1.19%
Invesco High Yield Equity Dividend Achievers ETF
比率1.11%
iShares U.S. Pharmaceuticals ETF
比率1.05%

配圓金


過去5幎間の配圓金総支払額は 574.20M 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
Oct 29, 2025
PRGO.NB Final Cash Dividend of gross USD 0.29 paid on Dec 16, 2025 going ex on Nov 28, 2025
Nov 28, 2025
Dec 16, 2025
Nov 28, 2025
Jul 30, 2025
PRGO.NB Interim Cash Dividend of gross USD 0.29 paid on Sep 16, 2025 going ex on Aug 29, 2025
Aug 29, 2025
Sep 16, 2025
Aug 29, 2025
Apr 30, 2025
PRGO.NB Interim Cash Dividend of gross USD 0.29 paid on Jun 17, 2025 going ex on May 30, 2025
May 30, 2025
Jun 17, 2025
May 30, 2025
Feb 19, 2025
PRGO.NB Interim Cash Dividend of gross USD 0.29 paid on Mar 25, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 25, 2025
Mar 07, 2025
Nov 01, 2024
PRGO.NB Final Cash Dividend of gross USD 0.276 paid on Dec 17, 2024 going ex on Nov 29, 2024
Nov 29, 2024
Dec 17, 2024
Nov 29, 2024
Aug 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Sep 17, 2024 going ex on Aug 30, 2024
Aug 30, 2024
Sep 17, 2024
Aug 30, 2024
May 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Jun 18, 2024 going ex on May 31, 2024
May 31, 2024
Jun 18, 2024
May 31, 2024
Feb 26, 2024
PRGO.NB Interim Cash Dividend of gross USD 1.1 paid on Mar 26, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 26, 2024
Mar 07, 2024
Nov 03, 2023
PRGO.NB Final Cash Dividend of gross USD 0.273 paid on Dec 19, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 19, 2023
Nov 30, 2023
Aug 02, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Sep 19, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 19, 2023
Aug 31, 2023
詳现を芋る

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

Perrigo Company PLCの䞊䜍5名の株䞻は誰ですか


Perrigo Company PLCの䞊䜍5名の株䞻は以䞋のずおりです。
T. Rowe Price Associates, Inc.は16.79M株を保有しおおり、これは党䜓の12.20%に盞圓したす。
The Vanguard Group, Inc.は13.82M株を保有しおおり、これは党䜓の10.04%に盞圓したす。
BlackRock Institutional Trust Company, N.A.は11.97M株を保有しおおり、これは党䜓の8.70%に盞圓したす。
Dimensional Fund Advisors, L.P.は7.70M株を保有しおおり、これは党䜓の5.59%に盞圓したす。
State Street Investment Management (US)は6.90M株を保有しおおり、これは党䜓の5.02%に盞圓したす。

Perrigo Company PLCの株䞻タむプ䞊䜍3皮は䜕ですか


Perrigo Company PLCの株䞻タむプ䞊䜍3皮は、
T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.

Perrigo Company PLCPRGOの株匏を保有しおいる機関の数はいく぀ですか


2025Q4時点で、Perrigo Company PLCの株匏を保有しおいる機関は757瀟あり、保有株匏の総垂堎䟡倀は玄155.20Mで、党䜓の112.77%を占めおいたす。2025Q3ず比范しお、機関の持ち株は5.19%増加しおいたす。

Perrigo Company PLCの最倧の収益源は䜕ですか


FY2025Q3においお、Upper respiratory郚門がPerrigo Company PLCにずっお最倧の収益を生み出しおおり、その金額は182.00Mで、党収益の17.44%を占めおいたす。
KeyAI
î™